Linkedin

Home
Startup Insight
Stories
Articles
Features

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Home Tags AMR Action Fund

AMR Action Fund

Elion Therapeutics, a biotechnology company dedicated to transforming the treatment of life-threatening invasive fungal infections (IFIs), has closed a $81 million Series B funding round led by Deerfield Management and the AMR Action Fund. Additional investors include Illinois Ventures.

[Funding News] Elion Therapeutics Closes $81 Mn Series B Funding Round...

Team SR - June 17, 2024

ABOUT US

Startup Rise - America is rapidly growing business media platform for entrepreneurs and startups to cover and publish their journeys through Video Talks, Interviews, Articles and News.

Contact us: contact@startuprise.io

FOLLOW US

© Copyright startuprise 2024 All Rights Reserved.

Newsletter

Subscribe to our weekly newsletter and don't forget to check out the latest updates.

EmailEnter your email address

Thanks, I’m not interested